Correction to: Journal of Hematology & Oncology (2016) 9:93 https://doi.org/10.1186/s13045-016-0327-5
The original article [1] contains an error in Fig. 4b, the panel of colonies of 5 µM Ara-C treatment was unintentionally duplicated onto the colonies of 2.5 µM alantolactone treatment. The error was mistakenly introduced in image integration when organizing the figures. However, the error has no bearing on the work’s scientific conclusions as the statistical results are based on the correct pictures. The authors apologize to the editor and readership of Journal of Hematology & Oncology for any inconvenience caused.
Alantolactone suppressed primary AML but not normal colony formation after 14 days in methocult H4434. a Alantolactone dramatically reduced the number of CFUs in primary AML cells from eight AML specimens with a dose-dependent manner. b The representative microscopy images of CFUs in primary AML cells were shown. c Alantolactone showed little effect on the CFUs in normal hematopoietic cells and Ara-C treatment led to notable reduction of colonies from normal donors. d The representative microscopy images of CFUs in normal hematopoietic cells were shown. *P < 0.05, **P < 0.01, ***P < 0.0001
Reference
Ding Y, Gao H, Zhang Y, Li Y, Vasdev N, Gao Y, Chen Y, Zhang Q. Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells. J Hematol Oncol. 2016;9:93.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Ding, Y., Gao, H., Zhang, Y. et al. Correction to: Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells. J Hematol Oncol 14, 61 (2021). https://doi.org/10.1186/s13045-021-01069-3
Published:
DOI: https://doi.org/10.1186/s13045-021-01069-3